AMRN is Dead Money....this company has no choice but to wait for Reduce-It. Every other suggestion from all of us disappointed investors on this board is just wishful thinking. Litigation, if it's expedited, will easily take 2 or even 3 years to get through the legal system to verdict. Probably longer than that. AMRN is going through the channel of appeals in FDA, so from my understanding that will take the remainder of 2014. Add that to the three years of litigation which commences after the appeals are exhausted and you're in 2018. Reduce it will have spoken by then.
FDA is not listening, not negotiating, and just simply does not care. You want proof: they delayed their decision on 1/15, which was their own deadline that they set after they missed the first deadline. Clearly this was not to examine any details or reconsider the facts. They delayed because they just didn't care enough to get around to saying no on 1/15. There was no further in depth analysis, no great insight, and most clearly no change of heart. FDA is feeling no pressure from the appeals process, threatened litigation, the CP, the epadruginitiative, or the threat to discontinue Reduce it.
It couldn't be clearer that there will be no positive news from FDA on Vascepa,ever. There will be no fruitful discussions, negotiations or threats that result in action. AMRN as a company, is at the bottom of the river with a cement block chained to it's ankle. There will be no partners or buyouts. There will be no change to the label or usage indication. All that's left is Reduce It. And Reduce It has to show positive results in reducing CVD events or else this company is toast. The odds of this happening are very small. Deep down we all know its not likely that reducing trigs is enough to significantly impact reducing cvd deaths. Reduce-it is not about helping inflammation, reducing dry eyes or all of the other great things Vascepa may be able to do. The objective is to reduce death, and based on that alone Vascepa likely will not be significant enough for FDA to expand usage. BP is in control and FDA has spoken. They are not mixing words. They are not being coy. They are crystal clear. This is dead money for at least 2+ years and the odds of success at that time are minute.
I am holding this useless stock because it is trading at fair value based upon current usage and cash on hand and mostly because I don't have much too money left in it to lose. I am not optimistic in the least that I will ever make any money back to help make up my 75% loss. You shouldn't be either. We need to face reality.....AMRN is dead money. You will have better upside in a savings account at your local bank.
Market Data 
Markets 
